CLVR vs. AMPE, ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, and BCTXW
Should you be buying Clever Leaves stock or one of its competitors? The main competitors of Clever Leaves include Ampio Pharmaceuticals (AMPE), 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), and BriaCell Therapeutics (BCTXW). These companies are all part of the "pharmaceutical products" industry.
Clever Leaves vs.
Clever Leaves (NASDAQ:CLVR) and Ampio Pharmaceuticals (NYSE:AMPE) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, risk, community ranking, earnings, valuation, media sentiment, profitability, analyst recommendations and dividends.
6.9% of Clever Leaves shares are held by institutional investors. Comparatively, 5.7% of Ampio Pharmaceuticals shares are held by institutional investors. 8.2% of Clever Leaves shares are held by company insiders. Comparatively, 3.3% of Ampio Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Ampio Pharmaceuticals has lower revenue, but higher earnings than Clever Leaves. Ampio Pharmaceuticals is trading at a lower price-to-earnings ratio than Clever Leaves, indicating that it is currently the more affordable of the two stocks.
In the previous week, Ampio Pharmaceuticals had 2 more articles in the media than Clever Leaves. MarketBeat recorded 2 mentions for Ampio Pharmaceuticals and 0 mentions for Clever Leaves. Clever Leaves' average media sentiment score of 0.00 equaled Ampio Pharmaceuticals'average media sentiment score.
Clever Leaves received 13 more outperform votes than Ampio Pharmaceuticals when rated by MarketBeat users. Likewise, 81.25% of users gave Clever Leaves an outperform vote while only 0.00% of users gave Ampio Pharmaceuticals an outperform vote.
Clever Leaves has a beta of 2821.76, suggesting that its share price is 282,076% more volatile than the S&P 500. Comparatively, Ampio Pharmaceuticals has a beta of 3.71, suggesting that its share price is 271% more volatile than the S&P 500.
Summary
Clever Leaves beats Ampio Pharmaceuticals on 7 of the 10 factors compared between the two stocks.
Get Clever Leaves News Delivered to You Automatically
Sign up to receive the latest news and ratings for CLVR and its competitors with MarketBeat's FREE daily newsletter.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Clever Leaves Competitors List
Related Companies and Tools
This page (NASDAQ:CLVR) was last updated on 1/30/2025 by MarketBeat.com Staff
Free CLVR Stock Alerts